arginyl-glycyl-aspartic acid has been researched along with carbon tetrachloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enjoji, M; Fukushima, M; Kobayashi, N; Kohjima, M; Kotoh, K; Morizono, S; Nakamuta, M; Nawata, H | 1 |
| Cui, Y; Li, X; Liu, H; Wang, D; Zhang, C; Zhang, Y; Zhang, Z | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and carbon tetrachloride
| Article | Year |
|---|---|
Arg-Gly-Asp (RGD) peptide ameliorates carbon tetrachloride-induced liver fibrosis via inhibition of collagen production and acceleration of collagenase activity.
Topics: Animals; Carbon Tetrachloride; Cell Line; Collagen; Collagenases; Gene Expression Regulation; Humans; Hydroxyproline; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinase 1; Oligopeptides; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1 | 2004 |
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.
Topics: Animals; Carbon Tetrachloride; Dextrans; Disease Models, Animal; Hepatic Stellate Cells; Integrin alphaVbeta3; Liver Cirrhosis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Oligopeptides; Rats | 2016 |